docetaxel and cyclophosphamide
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for docetaxel and cyclophosphamide, covering 2022-04-14 to 2026-08-06. Get the full timeline:
Most recent: Clinical Trial Results: Docetaxel and Cyclophosphamide Compared to Anthracycline-Based Chemotherapy in Treating Women With HER2-Negative Breast Cancer [Phase 3]